163 related articles for article (PubMed ID: 26432900)
1. Cytokine overproduction and crosslinker hypersensitivity are unlinked in Fanconi anemia macrophages.
Garbati MR; Hays LE; Rathbun RK; Jillette N; Chin K; Al-Dhalimy M; Agarwal A; Newell AE; Olson SB; Bagby GC
J Leukoc Biol; 2016 Mar; 99(3):455-65. PubMed ID: 26432900
[TBL] [Abstract][Full Text] [Related]
2. p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes.
Anur P; Yates J; Garbati MR; Vanderwerf S; Keeble W; Rathbun K; Hays LE; Tyner JW; Svahn J; Cappelli E; Dufour C; Bagby GC
Blood; 2012 Mar; 119(9):1992-2002. PubMed ID: 22234699
[TBL] [Abstract][Full Text] [Related]
3. FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages.
Garbati MR; Hays LE; Keeble W; Yates JE; Rathbun RK; Bagby GC
Blood; 2013 Oct; 122(18):3197-205. PubMed ID: 24046015
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.
Li J; Sejas DP; Zhang X; Qiu Y; Nattamai KJ; Rani R; Rathbun KR; Geiger H; Williams DA; Bagby GC; Pang Q
J Clin Invest; 2007 Nov; 117(11):3283-95. PubMed ID: 17960249
[TBL] [Abstract][Full Text] [Related]
5. TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.
Vanderwerf SM; Svahn J; Olson S; Rathbun RK; Harrington C; Yates J; Keeble W; Anderson DC; Anur P; Pereira NF; Pilonetto DV; Pasquini R; Bagby GC
Blood; 2009 Dec; 114(26):5290-8. PubMed ID: 19850743
[TBL] [Abstract][Full Text] [Related]
6. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.
Whitney MA; Royle G; Low MJ; Kelly MA; Axthelm MK; Reifsteck C; Olson S; Braun RE; Heinrich MC; Rathbun RK; Bagby GC; Grompe M
Blood; 1996 Jul; 88(1):49-58. PubMed ID: 8704201
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
8. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.
Zhang X; Sejas DP; Qiu Y; Williams DA; Pang Q
J Cell Sci; 2007 May; 120(Pt 9):1572-83. PubMed ID: 17405815
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
13. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.
Rosselli F; Sanceau J; Gluckman E; Wietzerbin J; Moustacchi E
Blood; 1994 Mar; 83(5):1216-25. PubMed ID: 8118026
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
16. The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents.
Kelley MR; Tritt R; Xu Y; New S; Freie B; Clapp DW; Deutsch WA
Mutat Res; 2001 Mar; 485(2):107-19. PubMed ID: 11182542
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of STAT1 in Fanconi anemia group A lymphoblasts correlate with the cells' sensitivity to DNA interstrand crosslinking drugs.
Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
Haematologica; 2013 May; 98(5):705-13. PubMed ID: 23585528
[TBL] [Abstract][Full Text] [Related]
18. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.
Godthelp BC; Artwert F; Joenje H; Zdzienicka MZ
Oncogene; 2002 Jul; 21(32):5002-5. PubMed ID: 12118380
[TBL] [Abstract][Full Text] [Related]
19. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C-induced DNA damage in Fanconi anemia: cross-linking or redox-mediated effects?
Pagano G; Zatterale A; Korkina LG
Blood; 1999 Feb; 93(3):1116-8. PubMed ID: 10025986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
